🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 4-week, multicenter, randomized, double-blind, parallel group and...
Status
Completed
Location
Ordination Dr. Robert Voves, 8330 Feldbach
Start Date
2016-03-08
Trial ID
NCT02683109
Treatments Being Tested
The objective of this study is to assess the efficacy and safety of 12 week...
Status
Completed
Location
1237.26.10620 Boehringer Ingelheim Investigational Site
Start Date
2013-11
Trial ID
NCT02006732
Treatments Being Tested
To demonstrate the efficacy of inhaled tiotropium + olodaterol via Respimat...
Status
Completed
Location
SEC Lung
Start Date
2020-01-08
Trial ID
NCT04223843
Treatments Being Tested
The aim of this trial is to evaluate the safety and efficacy of 2.5 and 5 µ...
Status
Completed
Location
205.464.81020 Boehringer Ingelheim Investigational Site
Start Date
2011-04
Trial ID
NCT01340209
Treatments Being Tested
Study to investigate safety and tolerability of single, inhaled doses (2.5 ...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT02259946
Treatments Being Tested
The study investigates the effect of 3 days of twice daily treatment of two...
Status
Completed
Location
Clinical Site Partners, LLC
Start Date
2018-07-16
Trial ID
NCT03673670
Treatments Being Tested
The objective of the trial is to compare the lung function profile of once ...
Status
Completed
Location
1237.11.32002 Boehringer Ingelheim Investigational Site
Start Date
2013-10
Trial ID
NCT01969721
The study is intended to characterize the lung function profile of BI1744 i...
Status
Completed
Location
1222.39.32003 Boehringer Ingelheim Investigational Site
Start Date
2010-01
Trial ID
NCT01040689
The primary objective of this trial is to investigate the effect of 6 weeks...
Status
Completed
Location
1237.14.01404 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01533935
Treatments Being Tested
The overall objective of this study is to assess efficacy and safety of 12 ...
Status
Completed
Location
1222.52.02090 Boehringer Ingelheim Investigational Site
Start Date
2012-09
Trial ID
NCT01696058
Treatments Being Tested